Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: A multicenter, placebo-controlled, double-blind study

Fredrick M. Wigley, Joseph H. Korn, M. E. Csuka, Thomas A. Medsger, Naomi F. Rothfield, Michael Ellman, Richard Martin, David H. Collier, Arthur Weinstein, Daniel E. Furst, Sergio A. Jimenez, Maureen D. Mayes, Peter A. Merkel, Barry Gruber, Lee Kaufman, John Varga, Patrice Bell, John Kern, Pran Marrott, Barbara WhiteRobert W. Simms, Andree C. Phillips, James R. Seibold

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: A multicenter, placebo-controlled, double-blind study'. Together they form a unique fingerprint.

Medicine & Life Sciences